Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Swale

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Wiley Interdisciplinary Reviews. RNA|March 30, 2023
3'-end mRNA processing within apicomplexan parasites, a patchwork of classic, and unexpected playersChristopher Swale, Mohamed-Ali Hakimi
Current Opinion in Microbiology|August 31, 2025
Decoding the epigenetic blueprint behind Toxoplasma (pre)sexual commitment and chronic persistenceMartina Shahinas, Belen Pachano, Marie G Robert, et al.
Current Opinion in Structural Biology|May 22, 2015
Polyproteins in structural biologyThibaut Crépin, Christopher Swale, Alexandre Monod, et al.
Journal of Virology|July 2, 2010
Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunitThibaut Crépin, Alexandre Dias, Andrés Palencia, et al.
Viruses|September 21, 2016
Binding of RNA by the Nucleoproteins of Influenza Viruses A and BAlice Labaronne, Christopher Swale, Alexandre Monod, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
GRA47 and GRA72 are <i>Toxoplasma gondii</i> pore-forming proteins that influence small molecule permeability of the parasitophorous vacuoleMebratu A Bitew, Pablo S Gaete, Christopher Swale, et al.
Mbio|February 21, 2024
Two <i>Toxoplasma gondii</i> putative pore-forming proteins, GRA47 and GRA72, influence small molecule permeability of the parasitophorous vacuoleMebratu A Bitew, Pablo S Gaete, Christopher Swale, et al.
Science Translational Medicine|November 8, 2019
Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls <i>Cryptosporidium</i> infectionChristopher Swale, Alexandre Bougdour, Audrey Gnahoui-David, et al.
Expert Opinion on Drug Discovery|March 21, 2015
Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaAlexandre Monod, Christopher Swale, Bogdan Tarus, et al.
Iscience|December 18, 2020
Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan ParasitesValeria Bellini, Christopher Swale, Marie-Pierre Brenier-Pinchart, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Wiley Interdisciplinary Reviews. RNA|March 30, 2023
3'-end mRNA processing within apicomplexan parasites, a patchwork of classic, and unexpected playersChristopher Swale, Mohamed-Ali Hakimi
Current Opinion in Microbiology|August 31, 2025
Decoding the epigenetic blueprint behind Toxoplasma (pre)sexual commitment and chronic persistenceMartina Shahinas, Belen Pachano, Marie G Robert, et al.
Current Opinion in Structural Biology|May 22, 2015
Polyproteins in structural biologyThibaut Crépin, Christopher Swale, Alexandre Monod, et al.
Journal of Virology|July 2, 2010
Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunitThibaut Crépin, Alexandre Dias, Andrés Palencia, et al.
Viruses|September 21, 2016
Binding of RNA by the Nucleoproteins of Influenza Viruses A and BAlice Labaronne, Christopher Swale, Alexandre Monod, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
GRA47 and GRA72 are <i>Toxoplasma gondii</i> pore-forming proteins that influence small molecule permeability of the parasitophorous vacuoleMebratu A Bitew, Pablo S Gaete, Christopher Swale, et al.
Mbio|February 21, 2024
Two <i>Toxoplasma gondii</i> putative pore-forming proteins, GRA47 and GRA72, influence small molecule permeability of the parasitophorous vacuoleMebratu A Bitew, Pablo S Gaete, Christopher Swale, et al.
Science Translational Medicine|November 8, 2019
Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls <i>Cryptosporidium</i> infectionChristopher Swale, Alexandre Bougdour, Audrey Gnahoui-David, et al.
Expert Opinion on Drug Discovery|March 21, 2015
Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaAlexandre Monod, Christopher Swale, Bogdan Tarus, et al.
Iscience|December 18, 2020
Target Identification of an Antimalarial Oxaborole Identifies AN13762 as an Alternative Chemotype for Targeting CPSF3 in Apicomplexan ParasitesValeria Bellini, Christopher Swale, Marie-Pierre Brenier-Pinchart, et al.
Pageof 3